[en] Introduction: Lung transplantation (LTx) is considered an effective surgical therapy in patients with chronic or end-stage cardiopulmonary disease and significant functional limitation. Both surgical and anesthetic management (including the perioperative period) has evolved significantly in the last two decades. A clear example of this is ECMO (extracorporeal membrane oxygenation) type cardiocirculatory support therapy, which improves the prognosis of the most complex cases. The Lung Transplant Unit at University Hospital of A Coruña (CHUAC) performs approximately 30 to 50 lung transplants per year and has been utilizing ECMO therapy as cardiocirculatory rescue therapy since 2017. Objectives: The aim of this study will be to analyze the acute postoperative complications of lung transplantation, study the mortality and survival of transplanted patients, as well as those treated with this cardiocirculatory support therapy. It is also of interest to compare the survival and mortality in lung transplant patients under ECMO therapy with patients of similar characteristics without ECMO cardiocirculatory support therapy. This will allow us to estimate the impact that the use of ECMO therapy has had on mortality and survival from its implementation to the present. Materials and Methods: A retrospective descriptive-analytical observational study of the possible factors influencing acute complications, short-term mortality and survival in the contemporary perioperative management of lung transplantation will be carried out. The study included patients transplanted at CHUAC from 2013 to 2023, both years included.

[gl] Introdución: O transplante pulmonar (TxP) considérase unha terapia cirúrxica efectiva en pacientes cunha enfermidade cardiopulmonar en estadio crónico ou terminal e importante limitación funcional. O manexo tanto cirúrxico como anestésico (incluíndo o período perioperatorio) evolucionou significativamente nas últimas dúas décadas. Unha clara mostra diso é a terapia de soporte cardiocirculatorio tipo ECMO (extracorporeal membrane oxygenation) que mellora o prognóstico dos casos máis complexos. A unidade de Transplante Pulmonar do Hospital Universitario de A Coruña (CHUAC) realiza aproximadamente entre 30 e 50 transplantes pulmonares ao ano, e desde o ano 2017 utiliza a terapia ECMO como terapia de rescate cardiocirculatorio. Obxectivos: O obxectivo deste estudo será analizar as complicacións agudas do postoperatorio do transplante pulmonar, estudar a mortalidade e supervivencia dos pacientes transplantados, así como os tratados con esta terapia de soporte cardiocirculatorio. Tamén é interesante comparar a supervivencia e a mortalidade en pacientes baixo terapia ECMO no transplante pulmonar versus pacientes, de similares características, sen terapia de soporte cardiocirculatorio tipo ECMO. Así se poderá estimar o impacto que tivo utilizar a terapia tipo ECMO na mortalidade e supervivencia desde a súa implantación ata a actualidade. Material e Métodos: Realizarase un estudo observacional descritivo-analítico retrospectivo dos posibles factores influentes nas complicacións agudas, mortalidade a curto prazo e supervivencia do manexo perioperatorio contemporáneo do transplante de pulmón. No estudo inclúense os pacientes transplantados no CHUAC desde o ano 2013 ata o ano 2023, ambos os anos incluídos.